Cargando…
Efficacy and Safety of mRNA SARS-CoV2 Vaccination in Heart Transplant Recipients
PURPOSE: Data on immunologic response to SARS-CoV2 vaccination in heart transplant recipients are scarce. We investigated the efficacy and safety of mRNA SARS-CoV2 vaccination in this patient population. METHODS: In a retrospective single-center study we included 54 consecutive adult heart transplan...
Autores principales: | Poglajen, G., Ihan, A., Žorž, N., Frljak, S., Petek, S., Pohar, K., Cerar, A., Zemljič, G., Okrajšek, R., Šebeštjen, M., Kneževič, I., Vrtovec, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988590/ http://dx.doi.org/10.1016/j.healun.2022.01.807 |
Ejemplares similares
-
(651) Long-Term Safety and Efficacy of Mrna Sars-Cov2 Vaccination in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2023) -
Outcomes of COVID-19 in Heart Transplant Recipients
por: Poglajen, G., et al.
Publicado: (2022) -
Long-Term Effects of Angiotensin Receptor–Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
por: Poglajen, Gregor, et al.
Publicado: (2020) -
CD34(+) Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy
por: Frljak, Sabina, et al.
Publicado: (2018) -
Transendocardial CD34(+) Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated Cardiomyopathy
por: Žorž, Neža, et al.
Publicado: (2022)